{
    "nct_id": "NCT01581749",
    "official_title": "Prospective Evaluation of Truebeam STX Stereotactic Body Radiosurgery for Low and Intermediate Risk Prostate Cancer",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* histologically proven prostate adenocarcinoma within 1 year of enrollment\n* Low risk: Gleason \\<or=6 \\& PSA \\<or=10 \\& Clinical Stage T1b-T2a,Nx or N0, Mx or M0\n* Intermediate risk:Gleason \\<or=6 \\& PSA\\<or=10 \\& Clinical Stage T2b OR Gleason=7 \\& PSA\\<or=10 \\& Clinical Stage T1b-T2b OR Gleason \\<or=6 \\& PSA \\> 10 \\& \\< or =20 \\& Clinical Stage T1b- T2b, Nx or NO, Mx or M0\n* ECOG Performance Status 0-1\n* No prior prostate radiation or other definitive therapy\n\nExclusion Criteria:\n\n* implanted hardware or other material that would prohibit treatment planning or delivery\n* chemotherapy for a malignancy within the previous 5 years\n* history of an invasive malignancy (other than this prostate cancer,or basal or squamous skin cancers) within prior 5 years\n* hormone ablation for 2 months prior to treatment or during treatment\n\nsex: MALE\n\nminimumAge: 21 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* histologically proven prostate adenocarcinoma within 1 year of enrollment\n* Low risk: Gleason <=6 & PSA <=10 & Clinical Stage T1b-T2a,Nx or N0, Mx or M0\n* Intermediate risk:Gleason <=6 & PSA<=10 & Clinical Stage T2b OR Gleason=7 & PSA<=10 & Clinical Stage T1b-T2b OR Gleason <=6 & PSA > 10 & <=20 & Clinical Stage T1b- T2b, Nx or NO, Mx or M0\n* ECOG Performance Status 0-1\n* No prior prostate radiation or other definitive therapy\n\nsex: MALE\n\nminimumAge: 21 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "exclusion": "* implanted hardware or other material that would prohibit treatment planning or delivery\n* chemotherapy for a malignancy within the previous 5 years\n* history of an invasive malignancy (other than this prostate cancer,or basal or squamous skin cancers) within prior 5 years\n* hormone ablation for 2 months prior to treatment or during treatment"
    }
}